Farther Finance Advisors LLC Buys 6,032 Shares of SPDR S&P Biotech ETF $XBI

Farther Finance Advisors LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 574.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,082 shares of the exchange traded fund’s stock after buying an additional 6,032 shares during the period. Farther Finance Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $587,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Provident Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 3,000.0% in the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after acquiring an additional 300 shares during the last quarter. Garrison Bradford & Associates Inc. acquired a new position in SPDR S&P Biotech ETF in the first quarter valued at approximately $39,000. Compass Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after purchasing an additional 200 shares in the last quarter. Golden State Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 319 shares in the last quarter. Finally, Avalon Trust Co acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $57,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $97.95 on Friday. The firm has a fifty day moving average price of $90.67 and a 200 day moving average price of $84.67. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47. The stock has a market cap of $5.33 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.